SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Gold Alan D

(Last) (First) (Middle)
17190 BERNARDO CENTER DRIVE

(Street)
SAN DIEGO CA 92128

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BioMed Realty Trust Inc [ BMR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman and CEO
3. Date of Earliest Transaction (Month/Day/Year)
04/29/2009
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/29/2009 C 25,000 A (1) 379,927 D
Common Stock 04/29/2009 S(2) 25,000 D $11.0412(3) 354,927 D
Common Stock 04/30/2009 C 25,000 A (1) 379,927 D
Common Stock 04/30/2009 S(2) 25,000 D $11.5975(4) 354,927 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Limited Partnership Units (5) 10/01/2005 (6) Common Stock 17,144 17,144 I By SciMed Prop III Inc.
Limited Partnership Units (5) 10/01/2005 (6) Common Stock 161,894 161,894 I By SunMar Investments, Inc.
Limited Partnership Units (5) 04/29/2009 C(1) 25,000 10/01/2005 (6) Common Stock 25,000 $0.00(7) 1,116,742 D
Limited Partnership Units (5) 04/30/2009 C(1) 25,000 10/01/2005 (6) Common Stock 25,000 $0.00(7) 1,091,742 D
LTIP Units(8) (8) (9) (10) Common Stock 110,000 110,000 D
Explanation of Responses:
1. The reporting person redeemed 25,000 Limited Partnership Units of BioMed Realty, L.P. (the "Operating Partnership"), which BioMed Realty Trust, Inc. (the "Company") elected to redeem in shares of common stock of the Company. Limited Partnership Units of the Company may be redeemed for cash in an amount equal to the then fair value of an equal number of shares of common stock or converted into an equal number of shares of common stock, as determined by the Company.
2. The shares covered by this Form 4 have been sold pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on February 19, 2009.
3. Reflects multiple sales transactions at share prices ranging from $11.00 to $11.20. Upon request by the Securities and Exchange Commission staff, the Company or a security holder of the Company, information shall be provided regarding the number of shares sold at each price.
4. Reflects multiple sales transactions at share prices ranging from $11.50 to $11.76. Upon request by the Securities and Exchange Commission staff, the Company or a security holder of the Company, information shall be provided regarding the number of shares sold at each price.
5. Limited Partnership Units in the Operating Partnership. Limited Partnership Units are redeemable for cash based upon the fair market value of an equivalent number of shares of common stock of the Company, or, at the election of the Company, shares of the Company's common stock on a 1-for-1 basis.
6. The Limited Partnership Units have no expiration date.
7. The Limited Partnership Units were received in exchange for the direct or indirect contribution to the Operating Partnership of certain partnership, membership or ownership interests in certain partnerships, limited liability companies and corporations which own, directly or indirectly, certain properties in California.
8. Profits interest units of the Operating Partnership. The LTIP Units are subject to time-based restrictions.
9. The LTIP units are subject to time-based restrictions. Upon the occurrence of certain "triggering events," the LTIP Units can overt time achieve full parity with common units of the Operating Pertnership for all purposes, and therefore accrete to an economic value equivalent to one share of common stock of the Company on a one-for-one basis. If such parity is reached, vested LTIP Units convert to common units of the Operating Partnership and then may be redeemed for cash in an amount equal to the then fair value of an equal number of shares of common stock or converted into an equal number of shares of common stock, as determined by the Company.
10. The LTIP Units do not have an expiration date.
Remarks:
Jonathan P. Klassen, Attorney-in-Fact 05/01/2009
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.